Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 767839, 20 pages
http://dx.doi.org/10.1155/2012/767839
Review Article

PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors

1Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA
2Department of Neuroscience and Cell Biology, Department of Anesthesiology, and Center for Biomedical Engineering, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA

Received 8 October 2011; Accepted 26 November 2011

Academic Editor: Rassoul Dinarvand

Copyright © 2012 Marxa Figueiredo and Rinat Esenaliev. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. V. Larina, B. M. Evers, T. V. Ashitkov, C. Bartels, K. V. Larin, and R. O. Esenaliev, “Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation,” Technology in Cancer Research and Treatment, vol. 4, no. 2, pp. 217–226, 2005. View at Google Scholar
  2. O. V. Chumakova, A. V. Liopo, B. M. Evers, and R. O. Esenaliev, “Effect of 5-fluorouracil, optison and ultrasound on MCF-7 cell viability,” Ultrasound in Medicine and Biology, vol. 32, no. 5, pp. 751–758, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. O. V. Chumakova, A. V. Liopo, V. G. Andreev et al., “Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo,” Cancer Letters, vol. 261, no. 2, pp. 215–225, 2008. View at Publisher · View at Google Scholar · View at PubMed
  4. O. Zolochevska, X. Xia, B. J. Williams, A. Ramsay, S. Li, and M. L. Figueiredo, “Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo,” Human Gene Therapy, vol. 22, no. 12, pp. 1537–1550, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. O. Zolochevska and M. L. Figueiredo, “Advances in sonoporation strategies for cancer,” Frontiers of Bioscience, vol. 4, pp. 988–1006, 2012. View at Google Scholar
  6. C. M. H. Newman and T. Bettinger, “Gene therapy progress and prospects: ultrasound for gene transfer,” Gene Therapy, vol. 14, no. 6, pp. 465–475, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. H. D. Liang, J. Tang, and M. Halliwell, “Sonoporation, drug delivery, and gene therapy,” Proceedings of the Institution of Mechanical Engineers, Part H, vol. 224, no. 2, pp. 343–361, 2010. View at Publisher · View at Google Scholar
  8. S. M. Stieger, C. F. Caskey, R. H. Adamson et al., “Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model,” Radiology, vol. 243, no. 1, pp. 112–121, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. P. Zhong, Y. Zhou, and S. Zhu, “Dynamics of bubble oscillation in constrained media and mechanisms of vessel rupture in SWL,” Ultrasound in Medicine and Biology, vol. 27, no. 1, pp. 119–134, 2001. View at Publisher · View at Google Scholar
  10. C. X. Deng, F. Sieling, H. Pan, and J. Cui, “Ultrasound-induced cell membrane porosity,” Ultrasound in Medicine and Biology, vol. 30, no. 4, pp. 519–526, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. M. Duvshani-Eshet, L. Baruch, E. Kesselman, E. Shimoni, and M. Machluf, “Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy,” Gene Therapy, vol. 13, no. 2, pp. 163–172, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. T. A. Tran, S. Roger, J. Y. le Guennec, F. Tranquart, and A. Bouakaz, “Effect of ultrasound-activated microbubbles on the cell electrophysiological properties,” Ultrasound in Medicine and Biology, vol. 33, no. 1, pp. 158–163, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. P. L. McNeil, “Repairing a torn cell surface: make way, lysosomes to the rescue,” Journal of Cell Science, vol. 115, part 5, pp. 873–879, 2002. View at Google Scholar
  14. P. L. McNeil and R. A. Steinhardt, “Loss, restoration, and maintenance of plasma membrane integrity,” Journal of Cell Biology, vol. 137, no. 1, pp. 1–4, 1997. View at Publisher · View at Google Scholar
  15. R. K. Schlicher, H. Radhakrishna, T. P. Tolentino, R. P. Apkarian, V. Zarnitsyn, and M. R. Prausnitz, “Mechanism of intracellular delivery by acoustic cavitation,” Ultrasound in Medicine and Biology, vol. 32, no. 6, pp. 915–924, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. A. Lawrie, A. F. Brisken, S. E. Francis, D. C. Cumberland, D. C. Crossman, and C. M. Newman, “Microbubble-enhanced ultrasound for vascular gene delivery,” Gene Therapy, vol. 7, no. 23, pp. 2023–2027, 2000. View at Publisher · View at Google Scholar · View at PubMed
  17. S. Mehier-Humbert, T. Bettinger, F. Yan, and R. H. Guy, “Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression,” Journal of Controlled Release, vol. 104, no. 1, pp. 203–211, 2005. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Koch, P. Pohl, U. Cobet, and N. G. Rainov, “Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects,” Ultrasound in Medicine and Biology, vol. 26, no. 5, pp. 897–903, 2000. View at Publisher · View at Google Scholar
  19. C. K. Holland and R. E. Apfel, “Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment,” Journal of the Acoustical Society of America, vol. 88, no. 5, pp. 2059–2069, 1990. View at Publisher · View at Google Scholar
  20. I. V. Larina, B. M. Evers, C. Bartels, T. V. Ashitkov, K. V. Larin, and R. O. Esenaliev, “Ultrasound-enhanced drug delivery for efficient cancer therapy,” in Proceedings of the 24th Annual International Conference of the IEEE Engineering in Medicine and Biology and the Annual Fall Meeting of the Biomedical Engineering Society EMBS/BMES Conference, Houston, Tex, USA, 2002.
  21. Y. Ivanova, B. M. Evers, R. Thomas, T. V. Ashitkov, and R. O. Esenaliev, “Nanoparticles and ultrasound for delivery of model macromolecular anti-cancer drugs in tumors,” in Proceedings of the 24th Annual International Conference of the IEEE Engineering in Medicine and Biology and the Annual Fall Meeting of the Biomedical Engineering Society EMBS/BMES Conference, Houston, Tex, USA, 2002.
  22. H. Hosseinkhani, T. Kushibiki, K. Matsumoto, T. Nakamura, and Y. Tabata, “Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation,” Cancer Gene Therapy, vol. 13, no. 5, pp. 479–489, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. H. Hosseinkhani, T. Aoyama, O. Ogawa, and Y. Tabata, “Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin,” Journal of Drug Targeting, vol. 10, no. 3, pp. 193–204, 2002. View at Publisher · View at Google Scholar · View at PubMed
  24. J. M. Lü, X. Wang, C. Marin-Muller et al., “Current advances in research and clinical applications of PLGA-based nanotechnology,” Expert Review of Molecular Diagnostics, vol. 9, no. 4, pp. 325–341, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. R. C. Mundargi, V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi, “Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives,” Journal of Controlled Release, vol. 125, no. 3, pp. 193–209, 2008. View at Publisher · View at Google Scholar · View at PubMed
  26. J. Panyam and V. Labhasetwar, “Biodegradable nanoparticles for drug and gene delivery to cells and tissue,” Advanced Drug Delivery Reviews, vol. 55, no. 3, pp. 329–347, 2003. View at Publisher · View at Google Scholar
  27. J. Panyam, M. M. Dali, S. K. Sahoo et al., “Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano-and microparticles,” Journal of Controlled Release, vol. 92, no. 1-2, pp. 173–187, 2003. View at Publisher · View at Google Scholar
  28. R. Langer, “Drug delivery and targeting,” Nature, vol. 392, no. 6679, pp. 5–10, 1998. View at Google Scholar
  29. C. S. Fishburn, “The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics,” Journal of Pharmaceutical Sciences, vol. 97, no. 10, pp. 4167–4183, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. I. V. Larina, B. M. Evers, and R. O. Esenaliev, “Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation,” Anticancer Research, vol. 25, no. 1, pp. 149–156, 2005. View at Google Scholar
  31. M. Schneider, “Characteristics of SonoVuetrade mark,” Echocardiography, vol. 16, no. 7, part 2, pp. 743–746, 1999. View at Google Scholar
  32. S. Podell, C. Burrascano, M. Gaal, B. Golec, J. Maniquis, and P. Mehlhaff, “Physical and biochemical stability of Optison, an injectable ultrasound contrast agent,” Biotechnology and Applied Biochemistry, vol. 30, part 3, pp. 213–223, 1999. View at Google Scholar
  33. X. Gao, K. S. Kim, and D. Liu, “Nonviral gene delivery: what we know and what is next,” AAPS Journal, vol. 9, no. 1, pp. E92–E104, 2007. View at Google Scholar
  34. W. F. Lai, “In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives,” Expert Review of Medical Devices, vol. 8, no. 2, pp. 173–185, 2011. View at Publisher · View at Google Scholar · View at PubMed
  35. O. Boussif, F. LezoualC'H, M. A. Zanta et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7297–7301, 1995. View at Publisher · View at Google Scholar
  36. A. Baker, M. Saltik, H. Lehrmann et al., “Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery,” Gene Therapy, vol. 4, no. 8, pp. 773–782, 1997. View at Google Scholar
  37. C. Meunier-Durmort, H. Grimai, L. M. Sachs, B. A. Demeneix, and C. Forest, “Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells,” Gene Therapy, vol. 4, no. 8, pp. 808–814, 1997. View at Google Scholar
  38. D. Fischer, T. Bieber, Y. Li, H. P. Elsässer, and T. Kissel, “A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity,” Pharmaceutical Research, vol. 16, no. 8, pp. 1273–1279, 1999. View at Publisher · View at Google Scholar
  39. L. Wightman, R. Kircheis, V. Rössler et al., “Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo,” Journal of Gene Medicine, vol. 3, no. 4, pp. 362–372, 2001. View at Publisher · View at Google Scholar · View at PubMed
  40. X. Q. Zhang, J. Intra, and A. K. Salem, “Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods,” Journal of Microencapsulation, vol. 25, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. M. Bivas-Benita, S. Romeijn, H. E. Junginger, and G. Borchard, “PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 58, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at PubMed
  42. C. Sonne, F. Xie, J. Lof et al., “Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems,” Journal of the American Society of Echocardiography, vol. 16, no. 11, pp. 1178–1185, 2003. View at Publisher · View at Google Scholar
  43. O. N. Gofrit, A. Shapiro, D. Pode et al., “Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer,” Urology, vol. 63, no. 3, pp. 466–471, 2004. View at Google Scholar
  44. R. G. Soderquist, E. M. Sloane, L. C. Loram et al., “Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration,” Pharmaceutical Research, vol. 27, no. 5, pp. 841–854, 2010. View at Publisher · View at Google Scholar · View at PubMed
  45. D. Fischer, A. von Harpe, K. Kunath, H. Petersen, Y. Li, and T. Kissel, “Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes,” Bioconjugate Chemistry, vol. 13, no. 5, pp. 1124–1133, 2002. View at Publisher · View at Google Scholar
  46. S. S. Parelkar, D. Chan-Seng, and T. Emrick, “Reconfiguring polylysine architectures for controlling polyplex binding and non-viral transfection,” Biomaterials, vol. 32, no. 9, pp. 2432–2444, 2011. View at Publisher · View at Google Scholar · View at PubMed
  47. G. Navarro, G. Maiwald, R. Haase et al., “Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery,” Journal of Controlled Release, vol. 146, no. 1, pp. 99–105, 2010. View at Publisher · View at Google Scholar · View at PubMed
  48. V. Russ, H. Elfberg, C. Thoma, J. Kloeckner, M. Ogris, and E. Wagner, “Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer,” Gene Therapy, vol. 15, no. 1, pp. 18–29, 2008. View at Publisher · View at Google Scholar · View at PubMed
  49. C. L. Waite and C. M. Roth, “Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density,” Biotechnology and Bioengineering, vol. 108, no. 12, pp. 2999–3008, 2011. View at Publisher · View at Google Scholar · View at PubMed
  50. C. L. Waite and C. M. Roth, “PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma,” Bioconjugate Chemistry, vol. 20, no. 10, pp. 1908–1916, 2009. View at Publisher · View at Google Scholar · View at PubMed
  51. T. I. Kim, H. J. Seo, J. S. Choi et al., “PAMAM-PEG-PAMAM: novel triblock copolymer as a biocompatible and efficient gene delivery carrier,” Biomacromolecules, vol. 5, no. 6, pp. 2487–2492, 2004. View at Publisher · View at Google Scholar · View at PubMed
  52. K. C. Wood, S. R. Little, R. Langer, and P. T. Hammond, “A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery,” Angewandte Chemie International Edition, vol. 44, no. 41, pp. 6704–6708, 2005. View at Publisher · View at Google Scholar · View at PubMed
  53. J. S. Choi, K. S. Ko, J. S. Park, Y. H. Kim, S. W. Kim, and M. Lee, “Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation,” International Journal of Pharmaceutics, vol. 320, no. 1-2, pp. 171–178, 2006. View at Publisher · View at Google Scholar · View at PubMed
  54. R. Qi, Y. Gao, Y. Tang et al., “PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression,” AAPS Journal, vol. 11, no. 3, pp. 395–405, 2009. View at Publisher · View at Google Scholar · View at PubMed
  55. K. Negishi, M. Kobayashi, I. Ochiai et al., “Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T,” Circulation Journal, vol. 74, no. 12, pp. 2734–2740, 2010. View at Publisher · View at Google Scholar
  56. J. Du, Q. S. Shi, Y. Sun et al., “Enhanced delivery of monomethoxypoly(ethylene glycol)-poly(lactic-co-glycolic acid)-poly l-lysine nanoparticles loading platelet-derived growth factor BB small interfering RNA by ultrasound and/or microbubbles to rat retinal pigment epithelium cells,” Journal of Gene Medicine, vol. 13, no. 6, pp. 312–323, 2011. View at Publisher · View at Google Scholar · View at PubMed
  57. J. C. Chappell, J. Song, C. W. Burke, A. L. Klibanov, and R. J. Price, “Targeted delivery of nanopartides bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis,” Small, vol. 4, no. 10, pp. 1769–1777, 2008. View at Publisher · View at Google Scholar · View at PubMed
  58. R. Díaz-López, N. Tsapis, M. Santin et al., “The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent,” Biomaterials, vol. 31, no. 7, pp. 1723–1731, 2010. View at Publisher · View at Google Scholar · View at PubMed
  59. H. Maeda, “The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting,” Advances in Enzyme Regulation, vol. 41, pp. 189–207, 2001. View at Publisher · View at Google Scholar
  60. M. M. Néstor, N. P. E. Kei, N. A. M. Guadalupe, M. E. S. Elisa, G. Q. Adriana, and Q. G. David, “Preparation and in vitro evaluation of poly(D,L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging,” Ultrasonics, vol. 51, no. 7, pp. 839–845, 2011. View at Publisher · View at Google Scholar · View at PubMed
  61. Y. Kohl, C. Kaiser, W. Bost et al., “Preparation and biological evaluation of multifunctional PLGA-nanoparticles designed for photoacoustic imaging,” Nanomedicine, vol. 7, no. 2, pp. 228–237, 2011. View at Publisher · View at Google Scholar · View at PubMed
  62. Y. Kohl, C. Kaiser, W. Bost et al., “Near-infrared dye-loaded PLGA nanoparticles prepared by spray drying for photoacoustic applications,” International Journal of Artificial Organs, vol. 34, no. 2, pp. 249–252, 2011. View at Publisher · View at Google Scholar
  63. N. K. Varde and D. W. Pack, “Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres,” Journal of Controlled Release, vol. 124, no. 3, pp. 172–180, 2007. View at Publisher · View at Google Scholar · View at PubMed
  64. V. Sanna, G. Pintus, P. Bandiera et al., “Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents,” Molecular Pharmaceutics, vol. 8, no. 3, pp. 748–757, 2011. View at Publisher · View at Google Scholar · View at PubMed
  65. K. P. Maresca, S. M. Hillier, F. J. Femia et al., “A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer,” Journal of Medicinal Chemistry, vol. 52, no. 2, pp. 347–357, 2009. View at Publisher · View at Google Scholar · View at PubMed
  66. C. Yu, Y. Hu, J. Duan et al., “Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro,” PLoS ONE, vol. 6, no. 9, Article ID e24077, 2011. View at Publisher · View at Google Scholar · View at PubMed
  67. S. Dhar, N. Kolishetti, S. J. Lippard, and O. C. Farokhzad, “Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 5, pp. 1850–1855, 2011. View at Publisher · View at Google Scholar · View at PubMed
  68. O. C. Farokhzad, J. Cheng, B. A. Teply et al., “Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 16, pp. 6315–6320, 2006. View at Publisher · View at Google Scholar · View at PubMed
  69. J. Guo, X. Gao, L. Su et al., “Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery,” Biomaterials, vol. 32, no. 31, pp. 8010–8020, 2011. View at Publisher · View at Google Scholar · View at PubMed
  70. J. S. Xu, J. Huang, R. Qin et al., “Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging,” Biomaterials, vol. 31, no. 7, pp. 1716–1722, 2010. View at Publisher · View at Google Scholar · View at PubMed
  71. G. A. Husseini and W. G. Pitt, “Micelles and nanoparticles for ultrasonic drug and gene delivery,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1137–1152, 2008. View at Publisher · View at Google Scholar · View at PubMed
  72. J. D. Lathia, L. Leodore, and M. A. Wheatley, “Polymeric contrast agent with targeting potential,” Ultrasonics, vol. 42, no. 1–9, pp. 763–768, 2004. View at Publisher · View at Google Scholar · View at PubMed
  73. M. A. Wheatley, J. D. Lathia, and K. L. Oum, “Polymeric ultrasound contrast agents targeted to integrins: importance of process methods and surface density of ligands,” Biomacromolecules, vol. 8, no. 2, pp. 516–522, 2007. View at Publisher · View at Google Scholar · View at PubMed
  74. H. Ding, K. T. Yong, I. Roy et al., “Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers,” Nanotechnology, vol. 22, no. 16, Article ID 165101, 2011. View at Publisher · View at Google Scholar · View at PubMed
  75. J. K. Willmann, R. Paulmurugan, K. Chen et al., “US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice,” Radiology, vol. 246, no. 2, pp. 508–518, 2008. View at Publisher · View at Google Scholar · View at PubMed
  76. S. Pochon, I. Tardy, P. Bussat et al., “BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis,” Investigative Radiology, vol. 45, no. 2, pp. 89–95, 2010. View at Publisher · View at Google Scholar · View at PubMed
  77. F. Fay, K. M. McLaughlin, D. M. Small et al., “Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery,” Biomaterials, vol. 32, no. 33, pp. 8645–8653, 2011. View at Publisher · View at Google Scholar · View at PubMed
  78. A. R. Braden, M. T. Kafka, L. Cunningham, H. Jones, and J. K. Vishwanatha, “Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth,” Journal of Nanoscience and Nanotechnology, vol. 9, no. 5, pp. 2856–2865, 2009. View at Publisher · View at Google Scholar
  79. S. Bisht and A. Maitra, “Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy,” Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, vol. 1, no. 4, pp. 415–425, 2009. View at Publisher · View at Google Scholar · View at PubMed
  80. H. S. Cho, Z. Dong, G. M. Pauletti et al., “Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment,” ACS Nano, vol. 4, no. 9, pp. 5398–5404, 2010. View at Publisher · View at Google Scholar · View at PubMed
  81. R. X. Xu, J. Huang, J. S. Xu et al., “Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer,” Journal of Biomedical Optics, vol. 14, no. 3, Article ID 034020, 2009. View at Publisher · View at Google Scholar · View at PubMed
  82. A. Singh, F. Dilnawaz, S. Mewar, U. Sharma, N. R. Jagannathan, and S. K. Sahoo, “Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy,” ACS Applied Materials & Interfaces, vol. 3, no. 3, pp. 842–856, 2011. View at Publisher · View at Google Scholar · View at PubMed